SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, FCRD, IMRA
Written by ABC AUDIO on October 16, 2022
NEW YORK, NY / ACCESSWIRE / October 16, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
LogicBio Therapeutics, Inc. (NASDAQ:LOGC)’s sale to AstraZeneca Rare Disease for $2.07 per share. If you are an LogicBio shareholder, click here to learn more about your rights and options.
First Eagle Alternative Capital BDC, Inc. (NASDAQ:FCRD)’s sale to Crescent Capital BDC, Inc. If you are a First Eagle shareholder, click here to learn more about your rights and options.
Imara Inc. (NASDAQ:IMRA)’s merger with Enliven Therapeutics, Inc. If you are an Imara shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
LogicBio Therapeutics, Inc. (NASDAQ:LOGC)’s sale to AstraZeneca Rare Disease for $2.07 per share. If you are an LogicBio shareholder, click here to learn more about your rights and options.
First Eagle Alternative Capital BDC, Inc. (NASDAQ:FCRD)’s sale to Crescent Capital BDC, Inc. If you are a First Eagle shareholder, click here to learn more about your rights and options.
Imara Inc. (NASDAQ:IMRA)’s merger with Enliven Therapeutics, Inc. If you are an Imara shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
